Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent
1974-10-09
1976-11-23
Goldberg, Jerome D.
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Reduced antigenicity, reduced ability to bind complement, or...
A61K 3702
Patent
active
039937542
ABSTRACT:
An improved method is provided for chemotherapy of malignant tumors by injection of antitumor drugs. The antitumor drug is encapsulated within liposomes and the liposomes containing the encapsulated drug are injected into the body. The encapsulated drug penetrates into the tumor cells where the drug is slowly released and induces degeneration and death of the tumor cells, while any toxicity to the host body is reduced. Liposome encapsulation of actinomycin D has been found to be particularly effective in treating cancerous abdominal tumors, while drastically reducing the toxicity of actinomycin D to the host.
REFERENCES:
drugs Used Against Cancer, NIH, Apr. 1972.
Cerny Elizabeth A.
Rahman Yueh-Erh
Carlson Dean E.
Churm Arthur A.
Fisher Robert J.
Goldberg Jerome D.
The United States of America as represented by the United States
LandOfFree
Liposome-encapsulated actinomycin for cancer chemotherapy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Liposome-encapsulated actinomycin for cancer chemotherapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Liposome-encapsulated actinomycin for cancer chemotherapy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-232193